Global Gene Therapy Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major 40 Countries or Regions

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • Gene therapy refers to the introduction of exogenous normal genes into target cells to correct or compensate for diseases caused by defective and abnormal genes in order to achieve therapeutic goals.

    In recent years, gene therapy has been used with increased frequency to treat a variety of rare and incurable diseases, such as cancer and genetic disorders. Increased funding for cellular gene therapy companies in European countries such as the UK is expected to drive the European market at a considerable growth rate. Moreover, European companies are committed to expand product distribution globally by obtaining approvals from several regulatory bodies. China is recognized as a global focus for the development of new therapies. In the current scenario, the number of ongoing clinical trials for gene therapies in China has surpassed the number of trials in the US. The Asia-Pacific gene therapy market is also expected to grow.

    Gene therapy can provide a fundamental solution to many difficult conditions such as cancer, and with the increasing research in biotechnology, more gene therapies will be found, which is expected to drive the gene therapy market.

    The Gene Therapy is expected to grow from USD XX.0 million in 2018 to USD XX.0 million by 2025, at a Compound Annual Growth Rate (CAGR) of 6.8% during the forecast period. The research provides insights for the global Gene Therapy market based on different Types, End-Users and Regions, and competitive landscape of these segments are analyzed in detail.

    A wide range of market influence factors are taken into consideration in the analysis, and potential developing factors for different Types, End-Users and Regions are also included in the report in order to figure out the most promising development trends in the Gene Therapy industry. For presenting the most potential investment fields in North America, Europe, Asia Pacific and Latin America, Middle East & Africa, the market capacity and consumption potential of more than 34 major powers are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Global Gene Therapy Market Segmentations:

    By Players:

    • Avalanche Bio

    • Celladon

    • Vical

    • Sangamo

    • Spark Therapeutics

    • Dimension Therapeutics

    • Advantagene

    By Types:

    • Lentivirus

    • AAV

    • Retrovirus & Gammaretrovirus

    • Modified Herpes Simplex Virus

    • Adenovirus

    • Non-viral Plasmid Vector

    By End-User:

    • Acute Lymphoblastic Leukemia (ALL)

    • Inherited Retinal Disease

    • Large B-cell Lymphoma

    • ADA-SCID

    • Melanoma (Lesions)

    • Beta-Thalassemia Major/SCD

    • Head & Neck Squamous Cell Carcinoma

    • Peripheral Arterial Disease

    • Spinal Muscular Atrophy (SMA)

    • Others

    By Regions:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • France

    • Italy

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

    • Spain

    • Belgium

    • Poland

    • Russia

    • Turkey

    • Others

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Australia and New Zealand

    • ASEAN Countries (Indonesia, Thailand, Malaysia, Singapore, Philippines, Vietnam, Others)

    Latin America, Middle East & Africa

    • GCC Countries (Saudi Arabia, United Arab Emirates, Qatar, Others)

    • Brazil

    • Nigeria

    • South Africa

    • Argentina

    • Others

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Gene Therapy Market

    • 1.3 Market Segmentation by Type

      • 1.3.1 Global Gene Therapy Market Size and Growth Rate of Lentivirus from 2014 to 2026

      • 1.3.2 Global Gene Therapy Market Size and Growth Rate of AAV from 2014 to 2026

      • 1.3.3 Global Gene Therapy Market Size and Growth Rate of Retrovirus & Gammaretrovirus from 2014 to 2026

      • 1.3.4 Global Gene Therapy Market Size and Growth Rate of Modified Herpes Simplex Virus from 2014 to 2026

      • 1.3.5 Global Gene Therapy Market Size and Growth Rate of Adenovirus from 2014 to 2026

      • 1.3.6 Global Gene Therapy Market Size and Growth Rate of Non-viral Plasmid Vector from 2014 to 2026

    • 1.4 Market Segmentation by End-Users

      • 1.4.1 Global Gene Therapy Market Size and Growth Rate of Acute Lymphoblastic Leukemia (ALL) from 2014 to 2026

      • 1.4.2 Global Gene Therapy Market Size and Growth Rate of Inherited Retinal Disease from 2014 to 2026

      • 1.4.3 Global Gene Therapy Market Size and Growth Rate of Large B-cell Lymphoma from 2014 to 2026

      • 1.4.4 Global Gene Therapy Market Size and Growth Rate of ADA-SCID from 2014 to 2026

      • 1.4.5 Global Gene Therapy Market Size and Growth Rate of Melanoma (Lesions) from 2014 to 2026

      • 1.4.6 Global Gene Therapy Market Size and Growth Rate of Beta-Thalassemia Major/SCD from 2014 to 2026

      • 1.4.7 Global Gene Therapy Market Size and Growth Rate of Head & Neck Squamous Cell Carcinoma from 2014 to 2026

      • 1.4.8 Global Gene Therapy Market Size and Growth Rate of Peripheral Arterial Disease from 2014 to 2026

      • 1.4.9 Global Gene Therapy Market Size and Growth Rate of Spinal Muscular Atrophy (SMA) from 2014 to 2026

      • 1.4.10 Global Gene Therapy Market Size and Growth Rate of Others from 2014 to 2026

    • 1.5 Market Segmentation by Regions

      • 1.5.1 North America Gene Therapy Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.1 United States Gene Therapy Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.2 Canada Gene Therapy Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.3 Mexico Gene Therapy Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 Europe Gene Therapy Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.1 Germany Gene Therapy Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.2 UK Gene Therapy Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.3 France Gene Therapy Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.4 Italy Gene Therapy Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.5 Nordic Countries Gene Therapy Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.6 Spain Gene Therapy Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.7 Belgium Gene Therapy Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.8 Poland Gene Therapy Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.9 Russia Gene Therapy Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.10 Turkey Gene Therapy Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 Asia-Pacific Gene Therapy Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.1 China Gene Therapy Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.2 Japan Gene Therapy Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.3 Australia and New Zealand Gene Therapy Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.4 India Gene Therapy Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.5 ASEAN Countries Gene Therapy Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.6 South Korea Gene Therapy Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Latin America, Middle East & Africa Gene Therapy Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.1 GCC Countries Gene Therapy Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.2 Brazil Gene Therapy Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.3 Nigeria Gene Therapy Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.4 South Africa Gene Therapy Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.5 Argentina Gene Therapy Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints 

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Gene Therapy Market by Types

    • 3.1 Product Development Trends of Different Types

    • 3.2 Commercial Product Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Gene Therapy by Major Types

      • 3.4.1 Gene Therapy Market Size and Growth Rate of Lentivirus

      • 3.4.2 Gene Therapy Market Size and Growth Rate of AAV

      • 3.4.3 Gene Therapy Market Size and Growth Rate of Retrovirus & Gammaretrovirus

      • 3.4.4 Gene Therapy Market Size and Growth Rate of Modified Herpes Simplex Virus

      • 3.4.5 Gene Therapy Market Size and Growth Rate of Adenovirus

      • 3.4.6 Gene Therapy Market Size and Growth Rate of Non-viral Plasmid Vector

    4 Segmentation of Gene Therapy Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Gene Therapy by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Gene Therapy in Acute Lymphoblastic Leukemia (ALL)

      • 4.4.2 Market Size and Growth Rate of Gene Therapy in Inherited Retinal Disease

      • 4.4.3 Market Size and Growth Rate of Gene Therapy in Large B-cell Lymphoma

      • 4.4.4 Market Size and Growth Rate of Gene Therapy in ADA-SCID

      • 4.4.5 Market Size and Growth Rate of Gene Therapy in Melanoma (Lesions)

      • 4.4.6 Market Size and Growth Rate of Gene Therapy in Beta-Thalassemia Major/SCD

      • 4.4.7 Market Size and Growth Rate of Gene Therapy in Head & Neck Squamous Cell Carcinoma

      • 4.4.8 Market Size and Growth Rate of Gene Therapy in Peripheral Arterial Disease

      • 4.4.9 Market Size and Growth Rate of Gene Therapy in Spinal Muscular Atrophy (SMA)

      • 4.4.10 Market Size and Growth Rate of Gene Therapy in Others

    5 Market Analysis by Major Regions

    • 5.1 Global Gene Therapy Production Analysis by Major Regions

    • 5.2 Global Gene Therapy Consumption Analysis by Major Regions

    • 5.3 Global Gene Therapy Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 North America Gene Therapy Production, Import, Consumption and Export Analysis 

      • 5.3.2 Europe Gene Therapy Production, Import, Consumption and Export Analysis

      • 5.3.3 Asia Pacific Gene Therapy Production, Import, Consumption and Export Analysis

      • 5.3.4 Latin America, Middle East & Africa Gene Therapy Production, Import, Consumption and Export Analysis

    6 Product Commodity of Gene Therapy Market in Major Countries

    • 6.1 Top 5 Export Countries in Gene Therapy market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries' Export Value Analysis in Gene Therapy market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries'  Export Volume Analysis in Gene Therapy market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Gene Therapy market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries' Import Value Analysis in Gene Therapy market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries' Import Volume Analysis in Gene Therapy market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7 North America Gene Therapy Landscape Analysis

    • 7.1 North America Gene Therapy Landscape Analysis by Major Types

    • 7.2 North America Gene Therapy Landscape Analysis by Major End-Users

    • 7.3 North America Gene Therapy Landscape Analysis by Major Countries

      • 7.3.1 United States Gene Therapy Market Volume and Growth Rate

      • 7.3.2 Canada Gene Therapy Market Volume and Growth Rate

      • 7.3.3 Mexico Gene Therapy Market Volume and Growth Rate

    8 Europe Gene Therapy Landscape Analysis

    • 8.1 Europe Gene Therapy Landscape Analysis by Major Types

    • 8.2 Europe Gene Therapy Landscape Analysis by Major End-Users

    • 8.3 Europe Gene Therapy Landscape Analysis by Major Countries

      • 8.3.1 Germany Gene Therapy Market Volume and Growth Rate

      • 8.3.2 UK Gene Therapy Market Volume and Growth Rate

      • 8.3.3 France Gene Therapy Market Volume and Growth Rate

      • 8.3.4 Italy Gene Therapy Market Volume and Growth Rate

      • 8.3.5 Nordic Countries Gene Therapy Market Volume and Growth Rate

      • 8.3.6 Spain Gene Therapy Market Volume and Growth Rate

      • 8.3.7 Belgium Gene Therapy Market Volume and Growth Rate

      • 8.3.8 Poland Gene Therapy Market Volume and Growth Rate

      • 8.3.9 Russia Gene Therapy Market Volume and Growth Rate

      • 8.3.10 Turkey Gene Therapy Market Volume and Growth Rate

    9 Asia Pacific Gene Therapy Landscape Analysis

    • 9.1 Asia Pacific Gene Therapy Landscape Analysis by Major Types

    • 9.2 Asia Pacific Gene Therapy Landscape Analysis by Major End-Users

    • 9.3 Asia Pacific Gene Therapy Landscape Analysis by Major Countries

      • 9.3.1 China Gene Therapy Market Volume and Growth Rate

      • 9.3.2 Japan Gene Therapy Market Volume and Growth Rate

      • 9.3.3 Australia and New Zealand Gene Therapy Market Volume and Growth Rate

      • 9.3.4 India Gene Therapy Market Volume and Growth Rate

      • 9.3.5 ASEAN Countries Gene Therapy Market Volume and Growth Rate

      • 9.3.6 South Korea Gene Therapy Market Volume and Growth Rate

    10 Latin America, Middle East & Africa Gene Therapy Landscape Analysis

    • 10.1 Latin America, Middle East & Africa Gene Therapy Landscape Analysis by Major Types

    • 10.2 Latin America, Middle East & Africa Gene Therapy Landscape Analysis by Major End-Users

    • 10.3 Latin America, Middle East & Africa Gene Therapy Landscape Analysis by Major Countries

      • 10.3.1 GCC Countries Gene Therapy Market Volume and Growth Rate

      • 10.3.2 Brazil Gene Therapy Market Volume and Growth Rate

      • 10.3.3 Nigeria Gene Therapy Market Volume and Growth Rate

      • 10.3.4 South Africa Gene Therapy Market Volume and Growth Rate 

      • 10.3.5 Argentina Gene Therapy Market Volume and Growth Rate

    11 Major Players Profile

    • 11.1 Avalanche Bio

      • 11.1.1 Avalanche Bio Company Profile and Recent Development

      • 11.1.2 Market Performance

      • 11.1.3 Product and Service Introduction

    • 11.2 Celladon

      • 11.2.1 Celladon Company Profile and Recent Development

      • 11.2.2 Market Performance

      • 11.2.3 Product and Service Introduction

    • 11.3 Vical

      • 11.3.1 Vical Company Profile and Recent Development

      • 11.3.2 Market Performance

      • 11.3.3 Product and Service Introduction

    • 11.4 Sangamo

      • 11.4.1 Sangamo Company Profile and Recent Development

      • 11.4.2 Market Performance

      • 11.4.3 Product and Service Introduction

    • 11.5 Spark Therapeutics

      • 11.5.1 Spark Therapeutics Company Profile and Recent Development

      • 11.5.2 Market Performance

      • 11.5.3 Product and Service Introduction

    • 11.6 Dimension Therapeutics

      • 11.6.1 Dimension Therapeutics Company Profile and Recent Development

      • 11.6.2 Market Performance

      • 11.6.3 Product and Service Introduction

    • 11.7 Advantagene

      • 11.7.1 Advantagene Company Profile and Recent Development

      • 11.7.2 Market Performance

      • 11.7.3 Product and Service Introduction

    12 Data Source and Research Methodology

    The List of Tables and Figures (Totals 116 Figures and 130 Tables)

    • Figure Product Picture

    • Figure Gene Therapy Market Size and Growth Rate of Lentivirus from 2014 to 2026

    • Figure Gene Therapy Market Size and Growth Rate of AAV from 2014 to 2026

    • Figure Gene Therapy Market Size and Growth Rate of Retrovirus & Gammaretrovirus from 2014 to 2026

    • Figure Gene Therapy Market Size and Growth Rate of Modified Herpes Simplex Virus from 2014 to 2026

    • Figure Gene Therapy Market Size and Growth Rate of Adenovirus from 2014 to 2026

    • Figure Gene Therapy Market Size and Growth Rate of Non-viral Plasmid Vector from 2014 to 2026

    • Figure Market Share by Type in 2014

    • Figure Market Share by Type in 2018

    • Figure Market Share by Type in 2026

    • Figure Global Gene Therapy Market Size and Growth Rate of Acute Lymphoblastic Leukemia (ALL) from 2014 to 2026

    • Figure Global Gene Therapy Market Size and Growth Rate of Inherited Retinal Disease from 2014 to 2026

    • Figure Global Gene Therapy Market Size and Growth Rate of Large B-cell Lymphoma from 2014 to 2026

    • Figure Global Gene Therapy Market Size and Growth Rate of ADA-SCID from 2014 to 2026

    • Figure Global Gene Therapy Market Size and Growth Rate of Melanoma (Lesions) from 2014 to 2026

    • Figure Global Gene Therapy Market Size and Growth Rate of Beta-Thalassemia Major/SCD from 2014 to 2026

    • Figure Global Gene Therapy Market Size and Growth Rate of Head & Neck Squamous Cell Carcinoma from 2014 to 2026

    • Figure Global Gene Therapy Market Size and Growth Rate of Peripheral Arterial Disease from 2014 to 2026

    • Figure Global Gene Therapy Market Size and Growth Rate of Spinal Muscular Atrophy (SMA) from 2014 to 2026

    • Figure Global Gene Therapy Market Size and Growth Rate of Others from 2014 to 2026

    • Figure Market Share by End-User in 2014

    • Figure Market Share by End-User in 2018

    • Figure Market Share by End-User in 2026

    • Figure North America Gene Therapy Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure United States Gene Therapy Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Gene Therapy Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Gene Therapy Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Europe Gene Therapy Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Germany Gene Therapy Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure UK Gene Therapy Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure France Gene Therapy Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Gene Therapy Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries Gene Therapy Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Gene Therapy Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Gene Therapy Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Gene Therapy Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Gene Therapy Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Gene Therapy Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Asia-Pacific Gene Therapy Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure China Gene Therapy Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Japan Gene Therapy Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Australia and New Zealand Gene Therapy Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure India Gene Therapy Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure ASEAN Countries Gene Therapy Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure South Korea Gene Therapy Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Latin America, Middle East & Africa Gene Therapy Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure GCC Countries Gene Therapy Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Brazil Gene Therapy Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Nigeria Gene Therapy Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure South Africa Gene Therapy Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Argentina Gene Therapy Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Gene Therapy Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2018

    • Figure Market Share of TOP 5 Players in 2018

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Gene Therapy

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Gene Therapy by Different Types from 2014 to 2026

    • Table Consumption Share of Gene Therapy by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Lentivirus

    • Figure Market Size and Growth Rate of AAV

    • Figure Market Size and Growth Rate of Retrovirus & Gammaretrovirus

    • Figure Market Size and Growth Rate of Modified Herpes Simplex Virus

    • Figure Market Size and Growth Rate of Adenovirus

    • Figure Market Size and Growth Rate of Non-viral Plasmid Vector

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Gene Therapy by Different End-Users from 2014 to 2026

    • Table Consumption Share of Gene Therapy by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Acute Lymphoblastic Leukemia (ALL)

    • Figure Market Size and Growth Rate of Inherited Retinal Disease

    • Figure Market Size and Growth Rate of Large B-cell Lymphoma

    • Figure Market Size and Growth Rate of ADA-SCID

    • Figure Market Size and Growth Rate of Melanoma (Lesions)

    • Figure Market Size and Growth Rate of Beta-Thalassemia Major/SCD

    • Figure Market Size and Growth Rate of Head & Neck Squamous Cell Carcinoma

    • Figure Market Size and Growth Rate of Peripheral Arterial Disease

    • Figure Market Size and Growth Rate of Spinal Muscular Atrophy (SMA)

    • Figure Market Size and Growth Rate of Others

    • Table Global Gene Therapy Production by Major Regions

    • Table Global Gene Therapy Production Share by Major Regions

    • Figure Global Gene Therapy Production Share by Major Regions in 2014

    • Figure Global Gene Therapy Production Share by Major Regions in 2018

    • Figure Global Gene Therapy Production Share by Major Regions in 2026

    • Table Global Gene Therapy Consumption by Major Regions

    • Table Global Gene Therapy Consumption Share by Major Regions

    • Figure Global Gene Therapy Consumption Share by Major Regions in 2014

    • Figure Global Gene Therapy Consumption Share by Major Regions in 2018

    • Figure Global Gene Therapy Consumption Share by Major Regions in 2026

    • Table North America Gene Therapy Production, Import, Consumption and Export Analysis

    • Table Europe Gene Therapy Production, Import, Consumption and Export Analysis

    • Table Asia Pacific Gene Therapy Production, Import, Consumption and Export Analysis

    • Table Latin America, Middle East & Africa Gene Therapy Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Gene Therapy market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Gene Therapy market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Gene Therapy market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Gene Therapy market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table North America Gene Therapy Consumption by Types from 2014 to 2026

    • Table North America Gene Therapy Consumption Share by Types from 2014 to 2026

    • Figure North America Gene Therapy Consumption Share by Types in 2014

    • Figure North America Gene Therapy Consumption Share by Types in 2018

    • Figure North America Gene Therapy Consumption Share by Types in 2026

    • Table North America Gene Therapy Consumption by End-Users from 2014 to 2026

    • Table North America Gene Therapy Consumption Share by End-Users from 2014 to 2026

    • Figure North America Gene Therapy Consumption Share by End-Users in 2014

    • Figure North America Gene Therapy Consumption Share by End-Users in 2018

    • Figure North America Gene Therapy Consumption Share by End-Users in 2026

    • Table North America Gene Therapy Consumption by Major Countries from 2014 to 2026

    • Table North America Gene Therapy Consumption Share by Major Countries from 2014 to 2026

    • Figure North America Gene Therapy Consumption Share by Major Countries in 2014

    • Figure North America Gene Therapy Consumption Share by Major Countries in 2018

    • Figure North America Gene Therapy Consumption Share by Major Countries in 2026

    • Figure United States Gene Therapy Market Volume and Growth Rate from 2014 to 2026

    • Figure Canada Gene Therapy Market Volume and Growth Rate from 2014 to 2026

    • Figure Mexico Gene Therapy Market Volume and Growth Rate from 2014 to 2026

    • Table Europe Gene Therapy Consumption by Types from 2014 to 2026

    • Table Europe Gene Therapy Consumption Share by Types from 2014 to 2026

    • Figure Europe Gene Therapy Consumption Share by Types in 2014

    • Figure Europe Gene Therapy Consumption Share by Types in 2018

    • Figure Europe Gene Therapy Consumption Share by Types in 2026

    • Table Europe Gene Therapy Consumption by End-Users from 2014 to 2026

    • Table Europe Gene Therapy Consumption Share by End-Users from 2014 to 2026

    • Figure Europe Gene Therapy Consumption Share by End-Users in 2014

    • Figure Europe Gene Therapy Consumption Share by End-Users in 2018

    • Figure Europe Gene Therapy Consumption Share by End-Users in 2026

    • Table Europe Gene Therapy Consumption by Major Countries from 2014 to 2026

    • Table Europe Gene Therapy Consumption Share by Major Countries from 2014 to 2026

    • Figure Europe Gene Therapy Consumption Share by Major Countries in 2014

    • Figure Europe Gene Therapy Consumption Share by Major Countries in 2018

    • Figure Europe Gene Therapy Consumption Share by Major Countries in 2026

    • Figure Germany Gene Therapy Market Volume and Growth Rate from 2014 to 2026

    • Figure UK Gene Therapy Market Volume and Growth Rate from 2014 to 2026

    • Figure France Gene Therapy Market Volume and Growth Rate from 2014 to 2026

    • Figure Italy Gene Therapy Market Volume and Growth Rate from 2014 to 2026

    • Figure Nordic Countries Gene Therapy Market Volume and Growth Rate from 2014 to 2026

    • Figure Belgium Gene Therapy Market Volume and Growth Rate from 2014 to 2026

    • Figure Poland Gene Therapy Market Volume and Growth Rate from 2014 to 2026

    • Figure Russia Gene Therapy Market Volume and Growth Rate from 2014 to 2026

    • Figure Turkey Gene Therapy Market Volume and Growth Rate from 2014 to 2026

    • Table Asia Pacific Gene Therapy Consumption by Types from 2014 to 2026

    • Table Asia Pacific Gene Therapy Consumption Share by Types from 2014 to 2026

    • Figure Asia Pacific Gene Therapy Consumption Share by Types in 2014

    • Figure Asia Pacific Gene Therapy Consumption Share by Types in 2018

    • Figure Asia Pacific Gene Therapy Consumption Share by Types in 2026

    • Table Asia Pacific Gene Therapy Consumption by End-Users from 2014 to 2026

    • Table Asia Pacific Gene Therapy Consumption Share by End-Users from 2014 to 2026

    • Figure Asia Pacific Gene Therapy Consumption Share by End-Users in 2014

    • Figure Asia Pacific Gene Therapy Consumption Share by End-Users in 2018

    • Figure Asia Pacific Gene Therapy Consumption Share by End-Users in 2026

    • Table Asia Pacific Gene Therapy Consumption by Major Countries from 2014 to 2026

    • Table Asia Pacific Gene Therapy Consumption Share by Major Countries from 2014 to 2026

    • Figure Asia Pacific Gene Therapy Consumption Share by Major Countries in 2014

    • Figure Asia Pacific Gene Therapy Consumption Share by Major Countries in 2018

    • Figure Asia Pacific Gene Therapy Consumption Share by Major Countries in 2026

    • Figure China Gene Therapy Market Volume and Growth Rate from 2014 to 2026

    • Figure Japan Gene Therapy Market Volume and Growth Rate from 2014 to 2026

    • Figure Australia and New ZealandGene Therapy Market Volume and Growth Rate from 2014 to 2026

    • Figure India Gene Therapy Market Volume and Growth Rate from 2014 to 2026

    • Figure ASEAN Countries Gene Therapy Market Volume and Growth Rate from 2014 to 2026

    • Figure South Korea Gene Therapy Market Volume and Growth Rate from 2014 to 2026

    • Table Latin America, Middle East & Africa Gene Therapy Consumption by Types from 2014 to 2026

    • Table Latin America, Middle East & Africa Gene Therapy Consumption Share by Types from 2014 to 2026

    • Figure Latin America, Middle East & Africa Gene Therapy Consumption Share by Types in 2014

    • Figure Latin America, Middle East & Africa Gene Therapy Consumption Share by Types in 2018

    • Figure Latin America, Middle East & Africa Gene Therapy Consumption Share by Types in 2026

    • Table Latin America, Middle East & Africa Gene Therapy Consumption by End-Users from 2014 to 2026

    • Table Latin America, Middle East & Africa Gene Therapy Consumption Share by End-Users from 2014 to 2026

    • Figure Latin America, Middle East & Africa Gene Therapy Consumption Share by End-Users in 2014

    • Figure Latin America, Middle East & Africa Gene Therapy Consumption Share by End-Users in 2018

    • Figure Latin America, Middle East & Africa Gene Therapy Consumption Share by End-Users in 2026

    • Table Latin America, Middle East & Africa Gene Therapy Consumption by Major Countries from 2014 to 2026

    • Table Latin America, Middle East & Africa Gene Therapy Consumption Share by Major Countries from 2014 to 2026

    • Figure Latin America, Middle East & Africa Gene Therapy Consumption Share by Major Countries in 2014

    • Figure Latin America, Middle East & Africa Gene Therapy Consumption Share by Major Countries in 2018

    • Figure Latin America, Middle East & Africa Gene Therapy Consumption Share by Major Countries in 2026

    • Figure GCC Countries Gene Therapy Market Volume and Growth Rate from 2014 to 2026

    • Figure Brazil Gene Therapy Market Volume and Growth Rate from 2014 to 2026

    • Figure Nigeria Gene Therapy Market Volume and Growth Rate from 2014 to 2026

    • Figure South Africa Gene Therapy Market Volume and Growth Rate from 2014 to 2026

    • Figure Argentina Gene Therapy Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of Avalanche Bio

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Avalanche Bio

    • Figure Sales and Growth Rate Analysis of Avalanche Bio

    • Figure Revenue and Market Share Analysis of Avalanche Bio

    • Table Product and Service Introduction of Avalanche Bio

    • Table Company Profile and Development Status of Celladon

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Celladon

    • Figure Sales and Growth Rate Analysis of Celladon

    • Figure Revenue and Market Share Analysis of Celladon

    • Table Product and Service Introduction of Celladon

    • Table Company Profile and Development Status of Vical

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Vical

    • Figure Sales and Growth Rate Analysis of Vical

    • Figure Revenue and Market Share Analysis of Vical

    • Table Product and Service Introduction of Vical

    • Table Company Profile and Development Status of Sangamo

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sangamo

    • Figure Sales and Growth Rate Analysis of Sangamo

    • Figure Revenue and Market Share Analysis of Sangamo

    • Table Product and Service Introduction of Sangamo

    • Table Company Profile and Development Status of Spark Therapeutics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Spark Therapeutics

    • Figure Sales and Growth Rate Analysis of Spark Therapeutics

    • Figure Revenue and Market Share Analysis of Spark Therapeutics

    • Table Product and Service Introduction of Spark Therapeutics

    • Table Company Profile and Development Status of Dimension Therapeutics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Dimension Therapeutics

    • Figure Sales and Growth Rate Analysis of Dimension Therapeutics

    • Figure Revenue and Market Share Analysis of Dimension Therapeutics

    • Table Product and Service Introduction of Dimension Therapeutics

    • Table Company Profile and Development Status of Advantagene

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Advantagene

    • Figure Sales and Growth Rate Analysis of Advantagene

    • Figure Revenue and Market Share Analysis of Advantagene

    • Table Product and Service Introduction of Advantagene


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.